US Patent Application for RECOMBINANT POXVIRUS BASED VACCINE AGAINST SARS-CoV-2 VIRUS Patent Application (Application #20210260182 issued August 26, 2021) - Jus..

The invention relates in various aspects to a recombinant poxvirus comprising a nucleic acid encoding a SARS-CoV-2 virus protein, methods for producing such viruses and the use of such viruses. The recombinant poxviruses are well suited, among others, as protective virus vaccines against SARS-CoV-2 ..